Adicet Bio Valuation
| ACET Stock | USD 7.98 0.01 0.13% |
At this time, the firm appears to be undervalued. Adicet Bio shows a prevailing Real Value of $21.13 per share. The current price of the firm is $7.98. Our model approximates the value of Adicet Bio from analyzing the firm fundamentals such as Shares Owned By Insiders of 0.90 %, current valuation of (5.96 M), and Return On Equity of -0.72 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Adicet Bio's valuation include:
Price Book 0.6993 | Enterprise Value | Enterprise Value Ebitda (1.21) | Price Sales 9.7185 | Enterprise Value Revenue 2.1386 |
Undervalued
Today
Please note that Adicet Bio's price fluctuation is not too volatile at this time. Calculation of the real value of Adicet Bio is based on 3 months time horizon. Increasing Adicet Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Adicet Bio's intrinsic value may or may not be the same as its current market price of 7.98, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.98 | Real 21.13 | Target 61.5 | Hype 8.33 | Naive 7.8 |
The intrinsic value of Adicet Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Adicet Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Adicet Bio helps investors to forecast how Adicet stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Adicet Bio more accurately as focusing exclusively on Adicet Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Adicet Bio's intrinsic value based on its ongoing forecasts of Adicet Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Adicet Bio's closest peers.
Adicet Bio Cash |
|
Adicet Revenue by Product
Adicet Bio Total Value Analysis
Adicet Bio is presently forecasted to have valuation of (5.96 M) with market capitalization of 76.61 M, debt of 17.23 M, and cash on hands of 260.64 M. The negative valuation of Adicet Bio may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Adicet Bio fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(5.96 M) | 76.61 M | 17.23 M | 260.64 M |
Adicet Bio Asset Utilization
One of the ways to look at asset utilization of Adicet is to check how much profit was generated for every dollar of assets it reports. Adicet Bio shows a negative utilization of assets of -0.39 percent, losing $0.003913 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Adicet Bio shows how discouraging it operates for each dollar spent on its assets.Adicet Bio Profitability Analysis
Considering Adicet Bio's profitability and operating efficiency indicators, Adicet Bio may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Adicet Bio's ability to earn profits and add value for shareholders.Net Loss | First Reported 2000-03-31 | Previous Quarter -31.2 M | Current Value -26.9 M | Quarterly Volatility 15.4 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.94 | 0.89 |
|
|
For Adicet Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Adicet Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Adicet Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Adicet Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Adicet Bio over time as well as its relative position and ranking within its peers.
Adicet Bio Earnings per Share Projection vs Actual
The next projected EPS of Adicet Bio is estimated to be -2.9233 with future projections ranging from a low of -3.2 to a high of -2.66. Adicet Bio's most recent 12-month trailing earnings per share (EPS TTM) is at -19.97. Please be aware that the consensus of earnings estimates for Adicet Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.Adicet Bio Earnings Estimation Breakdown
The calculation of Adicet Bio's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Adicet Bio is estimated to be -2.9233 with the future projection ranging from a low of -3.2 to a high of -2.66. Please be aware that this consensus of annual earnings estimates for Adicet Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-3.2 Lowest | Expected EPS | -2.66 Highest |
Adicet Bio Earnings Projection Consensus
Suppose the current estimates of Adicet Bio's value are higher than the current market price of the Adicet Bio stock. In this case, investors may conclude that Adicet Bio is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Adicet Bio's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 7 | 86.61% | 0.0 | -2.9233 | -19.97 |
Adicet Bio Ownership Allocation
The market capitalization of Adicet Bio is $76.61 Million. 30% of Adicet Bio outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Adicet Bio Profitability Analysis
Net Loss for the year was (117.12 M) with profit before overhead, payroll, taxes, and interest of 24.99 M.About Adicet Bio Valuation
The stock valuation mechanism determines Adicet Bio's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Adicet Bio based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Adicet Bio. We calculate exposure to Adicet Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Adicet Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -5.8 M | -5.5 M | |
| Pretax Profit Margin | (3.21) | (3.37) | |
| Operating Profit Margin | (3.34) | (3.51) | |
| Net Loss | (3.21) | (3.37) | |
| Gross Profit Margin | 0.89 | 0.94 |
Adicet Bio Current Valuation Indicators
Adicet Bio's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Adicet Bio's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Adicet Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Adicet Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Adicet Bio's worth.Additional Tools for Adicet Stock Analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.